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Infectious diseases caused by parasitic helminths are a major problem threatening health of domestic and 
wild animals and affecting agricultural industry worldwide. Treatment of helminthoses is based on 
administration of anthelmintic drugs, with benzimidazoles being the most important group. Unfortunately, the 
irrational use of similar anthelmintics has led to the development of drug resistance in helminths, thus 
causing a serious problem in the veterinary practice. Possible mechanisms of drug resistance development 
include changes of pharmacokinetic processes (changes in drug transport or increased drug deactivation), 
which are based on an increased activity of biotransformation enzymes and transporters in helminths. 
Understanding the mechanisms of drug resistance and defence strategies of parasites against drugs can 
prolong the efficacy of current anthelmintics and help to find new strategies for the control of helminthoses. 
Although drug metabolizing enzymes and transporters of helminths serve as an efficient defence against the 
negative action of xenobiotics, they have been relatively little investigated so far. Therefore, the aim of my 
doctoral thesis was to study the defence strategies of helminths, namely biotransformation enzymes, 
metabolic faith and transport of selected anthelmintic drugs, in the representatives of the main groups of 
parasitic helminths. From the class of flukes, we tested Dicrocoelium dendriticum. Haemonchus contortus 
was studied as a representative of group Nematoda and Hymenolepis diminuta served as a model organism 
of tapeworms. 
To achieve our goals, we performed in vitro (subcellular fractions of homogenate from parasites' bodies) and 
ex vivo (living parasites cultivated with medium) experiments. Activities of reduction enzymes, which play 
important role in parasites, were assayed towards model substrates. Anthelmintic drugs metabolized via 
carbonyl reduction in all examined species are represented by mebendazole (MBZ) and flubendazole (FLU). 
Although drug oxidation enzymes have not been considered to be important in helminths, obtained results in 
our experiments have confirmed the existence of an oxidative drug metabolism in these organisms. From the 
anthelmintics tested, albendazole (ABZ) undergoes sulphoxidation in D. dendriticum and H. contortus, but 
not in H. diminuta. Some helminths' oxidation enzymes, which play the significant role in defence against 
oxidative stress induced by redox-cycling drugs or host immune system, may contribute to the 
biotransformation of the drugs. From these enzymes, superoxide dismutase, catalase and peroxidase 
showed activity in all parasites. The ability to form methyl derivatives (D. dendriticum, H. diminuta) and 
glucose conjugates (H. contortus) have brought the first evidence that even helminths conjugate drugs with 
endogenous substrate in order to deactivate them. Comparison of sensitive and resistant isolates of H. 
contortus revealed higher formation of FLU metabolites in resistant individuals. It suggests that higher 
activity of biotransformation enzymes can contribute to the drug resistance development in this helminth 
species. Transport studies have confirmed a key role of passive diffusion in the transport of drugs in 
helminths. In the case of D. dendriticum the results indicated also the participation of active transport of ABZ 
and its sulphoxide. 
The obtained results expand the knowledge of defence strategies in helminths and prove that all tested 
helminths are able to effectively transform the structure of the drugs and other xenobiotics. By this way, 
parasites may be protected against toxic effects of drugs and it can contribute to the drug resistance in 
parasites. Therefore, the knowledge of drug biotransformation and transport in parasitic helminths may 
improve the pharmacotherapy of helminthoses in target species.      
